Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
Clinical trial NCT04372589 · COMPLETED
Trial details
- NCT number
- NCT04372589
- Sponsor
- University of Manitoba
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2021-05-17
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.